Table 3 TMS parameters of patents with multiple sclerosis and control subjects
From: Motor disability in patients with multiple sclerosis: transcranial magnetic stimulation study
Parameters | Patients (n = 52) | Controls (n = 52) | p value |
|---|---|---|---|
UL CL (ms) | 24.94 ± 4.7 | 19.98 ± 1.78 | < 0.001 |
UL MEP amplitude (mV) | 1.57 ± 1.5 | 1.18 ± 2.83 | < 0.001 |
UL RL (ms) | 12.91 ± 1.98 | 12.23 ± 1.45 | 0.049 |
UL CMCT (ms) | 11.87 ± 4.33 | 7.76 ± 1.53 | < 0.001 |
UL CMCT-f (ms) | 10.94 ± 4.23 | 6.81 ± 1.64 | < 0.001 |
LL CL (ms) | 50 ± 13.17 | 37.31 ± 3.73 | < 0.001 |
LL MEP amplitude (mV) | 0.73 ± 0.51 | 1.37 ± 1.15 | 0.001 |
LL RL (ms) | 23.82 ± 3.56 | 22.19 ± 2.8 | 0.012 |
LL CMCT (ms) | 27.42 ± 10.8 | 15.04 ± 2.98 | < 0.001 |
LL CMCT-f (ms) | 24.0 ± 10.87 | 12.32 ± 2.57 | < 0.001 |